Human osteoblasts can be induced from somatic cells by introducing defined factors, however, the strategy limits cells therapeutic applications for its multi-factor and complicated 
Introduction
The advance of induced pluripotent cells (iPSCs) from reprogramming somatic cells and transdifferentiation from one adult somatic tissue to another type have provided a promising cell source for application in regenerative medicine therapy (Li et al., 2005; Takahashi et al., 2006; Takahashi et al., 2007; Kriks et al., 2011) . The breaking discovery of iPSCs upon overexpression of four transcription factors (OCT4, KLF4, SOX2 and c-MYC) or by combination of small molecules has shed light on interrogating the mechanisms of cell fate reshaping (Takahashi et al., 2006; Takahashi et al., 2007; Bar-Nur et al., 2014) . Other cell fates have been stimulated to apply sets of lineage-instructive transcriptional factors (TFs) that may convert cells from a distinct lineage to another somatic cell type, also known as direct reprogramming or transdifferentiation, without passing through an intermediate pluripotent stage. Advances in effective cell-fate switching from fibroblasts into neurons, cardiomyocytes, ECs, and hepatocytes have been achieved (Ieda et al., 2010; Ginsberg et al., 2012; Margariti et al., 2012; Huang et al., 2014; Zhou et al., 2014) . However, these approaches for direct transdifferentiation between two lineage-specific cells employed multiple genetic factors. Such genetic manipulations may cast doubt on the utility of reprogrammed cells for their safety (Qian et al., 2012; Song et al., 2012) . Therefore, it is urgently needed to explore transdifferentiation with minimal genetic manipulation in a chemically defined setting. Especially, new strategies to induce fibroblasts into different cell lineages by replacing the destination cells reprogramming TFs with small molecules could achieve comparable transdifferentiation efficiency (Hou et al., 2013; Pennarossa et al., 2013; Sayed et al., 2015) .
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Osteocyte is the most abundant cell type in mature bone and play a crucial role in regulating the dynamic nature of bone (Schaffler et al., 2012) , which serves as a sensory network to respond to the effects of external influences. Osteocytes are derived from a subpopulation of committed osteoblasts which become buried in bone matrix to transform to multiple dendritic cells (Dallas et al., 2010) . During bone formation, the osteoblasts can either become embedded in bone as osteocytes, or become inactive osteoblasts (bone lining cells) (Manolagas et al., 2000) , whose fate is dependent on the bone signaling (Franz-Odendaal et al., 2006) . Meanwhile, osteoblasts serve as a central role in bone formation to produce a calcium and phosphate-based mineral that is deposited into the mineralized matrix of bone (Neve et al., 2011) . A functional osteoblast decline may cause osteolytic pathological conditions such as osteoporosis (Rachner et al., 2011) . Given the central role of osteocytes and osteoblasts in bone and system physiology, tremendous efforts have been spent to obtain these two kinds of cells in vitro and to understand the transition mechanism for cell-based therapies on patients with osteoporosis (Yamamoto et al., 2015; Mattinzoli et al., 2012; Krishnan et al., 2010) .
Recent achievements in osteoblasts induction from human fibroblasts have been reported by genetically introducing osteoblast-specific transcription factors (Runx2, Osterix) and reprogramming factors (Oct4, L-Myc) (Yamamoto et al., 2015) . However, the multiple and complicated ectopic transgenetic expressions inevitably harbor safety, efficiency and other technical issues. On the other hand, there have been no reports on the induction of human osteocytes using a fibroblast source from direct reprogramming. Thus, a substitution of ectopic TFs by treating with small molecules should be a desirable alternative to convert 5 directly somatic cells to ostoblast or osteocyte cells.
Here, we report a new strategy that combines the treatment of dexamethasone and a defined small-molecule cocktail consisting of CHIR99021 (GSK3 inhibitor) and forskolin (adenylyl cyclase activator) for osteoblast-osteocyte transdifferentiation. These compounds enabled the direct conversion of human fibroblasts into osteoblasts with only one TF, Runx2.
We also tested the capability of the converted osteoblast-like cells (iOBs) for bone forming in vivo. Moreover, these chemical cocktails could induce osteocytes from fibroblasts without any additional differentiation conditions. In summary, our study has established a means of obtaining a source of autologous osteoblasts and osteocytes for bone tissue engineering.
Results
Induction of osteoblasts from human fibroblasts by the combination of a defined factor and small molecules Several lines of evidence have supported the important role of osteogenic transcription factor Runx2 during bone development, which could effectively promote osteoblastic differentiation (Ducy et al., 1997; Karsenty et al., 1999; Komori et al., 1997) . Transduction with Runx2 induced osteogenic gene expression and mineralized matrix deposition in rat fibroblasts (Phillips et al., 2007) . To determine whether Runx2 is critical for fibroblast-osteoblastic cell conversion, we introduced Runx2 expression in primary human fibroblast cells from an 8-year boy. More than 40% Runx2-transduced cells were obtained after 3 days of infection (Supplementary information, Figure S1 ). Moreover, many proof-of-principle reports have demonstrated a crucial role for Wnt/beta-catenin signaling in 6 the early stage of bone formation by stimulation of Runx2 gene expression (Canalis et al., 2005; Gaur et al., 2005; Westendorf et al., 2004) . Wnt pathways have been shown to direct transdifferentiation of murine non-osteogenic cells into osteoblasts by inducing epigenetic modifications (Cho et al., 2014) . Furthermore, given that cAMP/PKA signaling also plays a prominent role in osteogenesis (Kang et al., 2004; Zhao et al., 2007) and ON through the combination treatment of CHIR and forskolin (DEX/F/CH). Noticeably, both COL1A1 and ON increased moderately in DEX/CH but remained the same in DEX/F, indicating that CHIR itself could induce osteoblastic genes and forskolin enhanced the expression only in presence of CHIR. And similar trend was observed in ALP expression.
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DEX/F moderately induced upregulation of OCN mRNA to the same extent of DEX/F/CH whereas DEX/CH exhibited similar OCN level compared to control (DEX), indicating CHIR has no effect in instigating OCN expression (1B). For BSP and OPN, either CH or F has any effect on their expression given that all conditions show the same mRNA levels relative to control. ALP staining confirmed the same results as real-time RT-PCR ( Figure 1C ).
We then examined the capability of calcium deposition in the four cultures by Alizarin Red staining (Paul et al., 1983) . It showed that DEX/F/CH treatment induced apparent calcium deposition on day25 ( Figure 1D ). Therefore, the most remarkable changes of osteoblast-like cells were elicited by the combination of DEX/F/CH. And the DEX/F/CH induced osteoblast-like cells (iOBs) were tested in the subsequent experiment.
Conversion efficiency of induced osteoblasts from human fibroblasts
To examine the efficiency of conversion from fibroblasts to iOBs, cells were dual-immunostained with Runx2 and Osterix on day 25 (Figure 2A ). Osterix is another critical regulator of osteoblast differentiation, and is an indicator for osteoblast. Figure S2 ).
To investigate whether iOBs could be derived from fibroblasts of another origin, and exclude off-target events, we transduced primary fibroblasts from three individual foreskin biopsies (HU001-HU003). All three primary human foreskin fibroblasts with Runx2 transduction by DEX/F/CH treatment evoked massive production of calcium deposition on day 25 ( Figure 2C ).
The heat map analysis showed that induced osteoblasts progressively expressed osteogenic gene. The expression pattern of iOBs was similar to that of BMSC-derived osteoblasts but distinguished from that of initial fibroblasts( Figure 2D ).
To exclude the possibility that iOBs could be derived from contaminating MSCs Figure S4A , B). No teratoma structures were observed in the cell implants or in the control site in all six mice. The size of implants was less than 1mm in diameter after 4 weeks ( Figure 3A , B). Polarized light microscopy of the deposited matrix showed the lamellar structure of new bone, which indicated that bone tissue had been remodeled by osteoblasts and osteoclasts. Under ultraviolet light, the intense green fluorescence illustrated new bone formation consistent with highly mineralized matrix ( Figure 3C ). Histological examination of the explanted grafts by Alizarin Red or Basic fuchsin staining also showed that mineralized bone matrix generation, new bone formation. And mineralizing osteoblasts could be detected lining on the side of the mineralized matrix ( Figure 3D , E).
The method was also applied to generate iOBs from rhesus monkey and tree shew Figure 4C ) and immunocytochemistry ( Figure 4D ). This result implied that exogenous transduced Runx2 was silenced gradually ( Figure 4B ) and the endogenous Runx2 was activated ( Figure 4C ) in the processing of osteogenic induction before day14. Transient expression of Runx2 transgene was sufficient to induce cell-fate conversion from day3 to day14. Meanwhile, our data showed that up-regulation of endogenous Runx2 required activation of Wnt signaling using CHIR, alone or in combination with forskolin from day14 and forskolin had marginal effects whereas DEX/F maintained transgene Runx2 expression at high level until day12 ( Figure 4B , C).
Another key feature of skeleton developing is the enhanced expression of alkaline phosphatase (ALP), which is an early osteogenic marker. In this study, for the first 14 days, 1 1 the efficiency of ALP induction was dependent on the treatment with the factor CHIR, forskolin, or the combination ( Figure 4E ). ALP was robustly induced in DEX/F/CH treated culture especially according to the quantification results on day14 ( Figure 4F ).
Dexamethasone alone treatment could increase the ALP expression at day6, but was reduced since then ( Figure 4G ). Gene expression analysis revealed peak expression of ALP under DEX/CH condition, but ALP expressing was reduced gradually from day 6 to day 10 ( Figure   4G ), indicating CH is able to stimulate ALP expression at an early time point and keeps ALP at a reduced level later on. Forskolin first repressed ALP expression in DEX/F and DEX/F/CH, but released its repression from day 6 and enhanced ALP expression on top of CH in DEX/F/CH ( Figure 4G ). ALP mRNA levels were up-regulated by 3 orders of magnitude at day 10 compared to the cells at day 6 in DEX/F cultures, but were approximately 5 times at day 10 higher than at day 6 in DEX/F/CH consequently ( Figure 4G ).
OCN is one of characteristics for osteoblasts. Induction of OCN high expression required activation of PKA signaling using forskolin alone by day 10 in DEX/F culture, but the expression began to decline since then ( Figure 4H ). Treatment with CHIR or the combination of CHIR and forskolin showed repressed OCN first and increased OCN expressing from day 10 ( Figure 4H ). Therefore, these findings suggested that the timing of defined chemical cocktails exposure would take significant effects on osteogenic gene expression levels. With the presence of CH and F together in the medium, cells were kept in a primed state until day 6
and ready for boosting ALP and OCN from day 10-day14. Thus both molecules are required for accurate timing for osteoblastic transdifferentiation. The remarkable phenotypic change was elicited by changing the timing of CHIR exposure from day11. Hereafter, we examined the characteristics of the induced osteocyte-like cells (iOCs) in the subsequent experiment.
Cell morphology and differentially expressed genes of iOCs
We then sought to characterize the in vitro properties of iOCs under DEX/F-DEX/F/CH 1 3 condition by day35. The fibroblasts cultured in basic medium of 10% FBS-DMEM showed elongated and spindle appearance, and the iOBs switched from fibroblast-like morphology to the retracted and stellate shape in DEX/F/CH ( Figure 6A ). But DEX/F-DEX/F/CH treated cells displayed a more elongated shape and dendrites which were more evident for interspersed ramified cellular elements at higher magnification (arrows) in iOCs ( Figure 6A ).
ALP staining showed that its expression was declined dramatically in iOCs treated with DEX/F-DEX/F/CH as compared with iOBs incubated with DEX/F/CH ( Figure 6B ).
Correspondingly, matrix mineralisation, as assessed by alizarin red staining, was most abundant in iOBs, whereas it was barely detectable in iOCs ( Figure 6B ).
A panel of characteristic osteocyte markers in iOBs and iOCs were detected on day 35 such as podoplanin (also known as E11/GP38), phosphate-regulating gene with homology to endopeptidases on X chromosome (PHEX), connexin 43 (CX43), dentin matrix protein 1 (DMP1) and sclerostin (SOST) ( Figure 6C ). GP38, PHEX and CX43 were expressed in both iOBs and iOCs while DMP1and SOST were detected only in iOCs ( Figure 6C ). Our result of CX43 expression was in line with the reported evidences that CX43 played important role in function and survival of both osteoblasts and osteocytes. Given GP38 and PHEX expressed in iOBs population while no DMP1 and SOST observed in them, an "incomplete conversion"
for osteocytes may exist under DEX/F/CH treatment. Accordingly, the majority of cells had cobblestone like features and the ramified cells were hardly observed in iOBs culture. But under DEX/F-DEX/F/CH procedure, the genes that were osteocyte specific or highly expressed in osteocytes have been all detected in iOCs population including DMP1 and SOST, implying that iOCs shared similar gene expression signature with osteocytes. Therefore，the 1 4 iOC gene expression profiling needs to be further analyzed.
Discussion
First of all, this is the first study demonstrating that osteocytic reprogramming can be achieved from human fibroblast cells. In this study, the iOCs are characterized by the formation of dendritic processes with a reduction in cytoplasmic volume and low level of mineralisation and alkaline phosphatase production (Dallas et al., 2010; Kato et al., 2001) , i.e., Wnts stimulate Runx2 gene expression (Westendorf et al., 2004; Gaur et al., 2005; Canalis et al., 2004) , and promote osteoblast precursor growth and some early events in osteoblast differentiation by changing ALP activity (Westendorf et al., 2004) . Recent studies have shown that the activation of the cAMP/PKA pathway is crucial for bone development and can stimulate the osteogenic gene expression (Yang et al., 2004; Zhao et al., 2007) .
Therefore, the chemical cocktail combined with only one lineage-specific TF, Runx2 may be sufficient to up-regulate osteogenic gene expression specifically and erase fibroblast gene expression.
But it is interesting that once the cells were primed with DEX/F first followed by Yamamoto's study demonstrates that Osterix plays a crucial role on osteoblasts "full conversion", the endogenous Osterix expression could be achieved by the small molecules combination in our research without the TF transduced. This technology of small molecules reprogramming would provide an alternative for the study of osteogenic cell-fate switching.
However, the precise mechanisms underlying the osteoblast reprogramming by combined exposure to Dex/F/CHIR and Runx2 transgene remain to be determined.
In conclusion, our study offers another strategy for the generation of individual specific osteoblasts and osteocytes which would provide desirable cell resources for disease modeling and for cell-based therapy against bone resorptive diseases.
Materials and Methods

Culture of human fibroblast cell
Primary fibroblasts were harvested from 8-year old male cells (passages 4-8) were expanded in growth medium consisting of DMEM (GIBCO), 10% fetal bovine serum (FBS) (Hyclone), 100 U/ml penicillin and 100 μ g/ml streptomycin antibiotics (sigma) and all other cell culture supplements and reagents were acquired from Sigma. Other three fibroblasts 1 7
(HU001, HU002, HU003) were obtained from three adult persons' foreskin respectively.
Lentiviral transduction
The Runx2 lentiviral vector was pCMV-VSV-G system to express the human Runx2 gene tagged with GFP, and the empty vector control lacked Runx2 insert. Plasmid DNA was purified from transformed Escherichia coli using plasmid DNA Purification kits (promega).
Lentiviruses were packaged using Lipofectamine 2000 (Invitrogen) as described elsewhere and got a high titer virus. Human skin fibroblasts of passage 4-8 was transduced by CSC-Runx2-ires-GFP or empty CSC-ires-GFP lentivirus as control at 40-60% confluence maintained in 10% FBS DEME medium with 100U/ml penicillin and 100 μ g/ml streptomycin antibiotics for three days at the beginning. Runx2-transduced cells were analyzed for transduction efficiency using quantification of GFP expression via flow cytometry (BD FCs Jazz cell sorter) after 72 hours.
Osteoblastic and osteocytes cells induction.
In osteogenic cells induction, we referred to 'DEX' treatment as exposure of cells to steroid hormone dexamethasone (10 nM, sigma) in the basic medium including 10% FBS (Hyclone), 100 U/ml penicillin (Sigma), 100 μ g/ml streptomycin (Sigma), DMDM (Gibco).
In other groups, 'DEX/F' as exposure to dexamethasone (10nM) and forskolin (10 μ M,Enzo), 'DEX/CH' as dexamethasone (10 nM) and CHIR99021(9 μ M,Stegment) and 'DEX/F/CH' as the combination of dexamethasone (10 nM), forskolin (10 μ M, Enzo) and CHIR99021 (9 μ M, Selleck) in the basic medium from day0 to day25. And the cells at day25 1 8
were used for transplantation studies. For osteocytes induction, cells were maintained in DEX/F/CH till day35.
Gene expression analyses
Total RNA was extracted during differentiation at day 3, 6, 10, 14 and 25 from each condition of DEX, DEX/F, DEX/CH and DEX/F/CH using an RNeasy kit (Qiagen). For qRT-PCR analyses, total RNA at each condition was reverse transcribed (Takara) and amplified material was detected using commercially SYBR green probes (Takara) with the data normalized to HPRT control. All results were from 3-5 technical replicates of 2-3 independent biological samples at each data point. Some of primers were the same as previously reported (Boukhechba et al., 2009; Phillips et al., 2007) .
Animal surgery
All animal procedures were carried out under the local Institutional Animal Care and Use committee (IACUC). Mice: A total number of 6 B6SJLF1 mice (20-35 g) were used in this study. They were anaesthetized with ketamine (90 mg/kg; Gutian, China). In vivo bone formation assays, a 1-2 cm skin incision was made to create a subcutaneous pocket. A total of 3x10 5 cells mixed with matrigel (BD) in total 100 μ l were placed into the pocket of right lumbar back in one mouse, and the contralateral side was injected with matrigel (BD) of same volume. After surgery, mice were put back to their original cages. The mice received injection in the subcutaneous site using ciclosporin (4 mg/kg) everyday. The mice were housed with free access to food and water. 
